Abstract
Oral mucositis is a severe component of the acute radiation syndrome. The present study was initiated to determine the potential of recombinant human keratinocyte growth factor (rHuKGF, Palifermin) to ameliorate oral mucositis in a mouse model after a single radiation exposure. A 3 × 3 mm2 area in the center of the lower tongue surface of C3H/Neu mice was irradiated with graded single doses of 25 kV X-rays. Acute mucosal ulceration was used as the quantal end-point for dose–response analyses. Palifermin was applied at a dose of 15 mg/kg on days 0, 1, 2, 3, 4 or 5. For comparison, three injections of 5 or 15 mg/kg on days 1–3 were administered. The ED50 (dose at which ulceration is expected in 50% of the animals) for irradiation alone was 11.6 ± 1.2 Gy. Mean latent time was 9.4 ± 0.2 days; mean ulcer duration was 2.8 ± 0.2 days. Single injections of rHuKGF did not result in a significant increase in isoeffective radiation doses at any of the administration days. However, the latent time to ulceration was significantly shortened by 1–2 days in all protocols. Repeated administration of rHuKGF (15 mg/kg) resulted a significant increase in ED50 to 16.8 ± 4.0 Gy (P = 0.0047); the mean latent time was 4.4 ± 0.9 days. Three injections of 5 mg/kg of Palifermin on days 1–3 yielded an ED50 of 19.4 ± 1.7 Gy. In this protocol, mean latent time was 6.6 ± 0.6 days. In conclusion, Palifermin has a potential to reduce the mucositis burden in patients after a single radiation exposure. Repeated injections are required. For three injections, a negative dose-effect of rHuKGF was observed. The optimum dose, number and timing of the administration require further investigation.
Similar content being viewed by others
References
Rubin JS, Bottaro DB, Chedid M, Miki T, Ron D, Cheon HG, Taylor WG, Fortney E, Sakata H, Finch PW, La Rochelle WJ (1995) Keratinocyte growth factor. Cell Biol Int 19:399–411
Farrell CL, Rex KL, Chen JN, Bready JV, Dipalma CR, Kaufman SA, Rattan A, Scully S, Lacey DL (2002) The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Prolif 35(Suppl 1):1–8
Werner S (1998) Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev 9:153–165
Danilenko DM (1999) Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor. Toxicol Pathol 27:64–71
Dörr W (2003) Oral mucosa: response modification by keratinocyte growth factor. In: Nieder C, Milas L, Ang KK (eds) Biological modification of radiation response. Springer, Berlin Heidelberg New York, pp 113–122
Dörr W, Noack R, Spekl K, Farrell CL (2001) Modification of oral mucositis by keratinocyte growth factor: single radiation exposure. Int J Radiat Biol 77:341–347
Dörr W, Spekl K, Farell CL (2002) The effect of keratinocyte growth factor on healing of manifest radiation ulcers in mouse tongue epithelium. Cell Prolif 35:86–92
Dörr W, Heider K, Spekl K (2005) Reduction of oral mucositis by palifermin (rHuKGF): dose–effect of rHuKGF. Int J Radiat Biol 81(8):557–565
Dörr W, Brankovic K, Hartmann B (2000) Repopulation in mouse oral mucosa: changes in the effect of dose fractionation. Int J Radiat Biol 76:383–390
SAS Institute INC (1990a) SAS/STAT user’s guide, version 6. SAS Institute, Cary
SAS Institute INC (1990b) SAS/STAT user’s guide, version 6. SAS Institute, Cary, pp 892–906
SAS Institute INC (1990c) SAS/STAT user’s guide, version 6. SAS Institute, Cary, pp 1324–1350
Dörr W, Emmendörfer H, Weber-Frisch M (1996) Tissue kinetics in mouse during daily fractionated radiotherapy. Cell Prolif 29:495–504
Liu K, Kasper M, Trott KR (1996) Changes in keratinocyte differentiation during accelerated repopulation of the irradiated mouse epidermis. Int J Radiat Biol 69:763–769
Van Der Schueren E, Van Den Bogaert W, Vanuystel L, Van Limbergen E (1990) Radiotherapy by multiply fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa. Int J Radiat Oncol Biol Phys 19:301–311
Denham JW, Peters LJ, Johansen J, Pulsen M, Lamb DS, Hindley A, O’Brien PC, Spry NA, Penminent M, Krawitz H, Williamson S, Bear J, Tripcony L (1999) Do acute mucosal reactions lead to consequential late reactions patients with head and neck cancer? Radiother Oncol 52:157–164
Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewelramani T, Shea T, Yanowich S, Hansen K, Noga S, McCarty J, Lemaistre CF, Sung EC, Blazar BR, Elhardt D, Chen MG, Emmanouilides C (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351(25):2590–2598
Farrell CL, Rex KL, Kaufman SA, Di Palma CR, Chen JN, Scully S, Lacey DL (1999) Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice. Int J Radiat Biol 75:609–620
Dörr W (1997) Three A’s of repopulation during fractionated irradiation in squamous epithelia: asymmetry loss, acceleration of stem- cell divisions and abortive divisions. Int J Radiat Biol 72:635–643
Dörr W (2003) Modulation of repopulation processes in oral mucosa: experimental results. Int J Radiat Biol 79:531–537
Klammt S (2005) Modification of oral mucositis (mouse) by keratinocyte growth factor (rHuKGF, Palifermin) after single radiation exposure: histological and immunhistochemical investigations. MDS Thesis. University of Technology, Dresden
Acknowledgments
This work was supported in part by AMGEN Inc. (Thousand Oaks, CA, USA). The authors are grateful to Mrs. K. Spekl and Mrs. D. Pfitzmann, for skilful assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kiliç, Y., Rajewski, K. & Dörr, W. Effect of post-exposure administration of keratinocyte growth factor (Palifermin) on radiation effects in oral mucosa in mice. Radiat Environ Biophys 46, 13–19 (2007). https://doi.org/10.1007/s00411-006-0079-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00411-006-0079-7